바로가기메뉴

본문 바로가기 주메뉴 바로가기

Investigation of the Growth Rate Change in Recombinant BCG which was cloned Mycobacterium tuberculosis Adenylate Kinase Mutation Gene or Human Muscle-type Adenylate Kinase Synthetic Gene.

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.60 no.2, pp.187-193




  • Downloaded
  • Viewed

Abstract

Background : Normal cell proliferation and viability is strongly depends on the availability of metabolic energy and the maintenance of the appropriate adenylate-nucleotide pools. Hypothetically, changes in adenylate kinase (AK) expression could therefore be associated with adaptation to altered growth characteristics or inversely altered growth characteristics of proliferating cells could drive the changes in the metabolic profile. This study investigated whether the expression of either AK1 or a Mycobacterium tuberculosis adenylate kinase mutant which has the same catalytic activity of AK1 could affect the growth rate of slow-growing BCG. Method : Recombinant BCGs, which were cloned the human muscle-type adenylate kinase synthetic gene (AK1) and adenylate kinase mutation gene (AKmtDM) of Mycobacterium tuberculosis into the Mycobacterium/E.coli expression vectors, were constructed. Recombinant BCGs and wild-type BCG were cultured in 7H9 media and the optical density at 600nm was measured at intervals of 2-3 days.Result : There wasn't the growth rate change induced by AK1 or AKmtDM expression in recombinant BCGs. Conclusion : The expression of AK1 or Mycobacterium tuberculosis adenylate kinase mutant in BCG does not affect the growth rate of BCG.(Tuberc Respir Dis 2006; 60: 187-193)

keywords
Adenylate kinase, Mutation, Growth rate, BCG, Adenylate kinase, Mutation, Growth rate, BCG

Reference

1.

(1998) Adenylate kinase:kinetic behavior in intact cells indicates it is integral to multiple cellular processes,

2.

(1995) Adenylate kinase-catalyzed phosphoryl transfer couples ATP utilization with its generation by glycolysis in intact muscle,

3.

(2000) Phosphorylation of nucleosides and nucleoside analogues by mammalian nucleoside monophosphate kinases,

4.

(1999) Identification of a novel human adenylate kinase:cDNA cloning,expression analysis,chromosome localization and characterization of the recombinant protein,

5.

(1996) Ancient divergence of long and short isoforms of adenylate kinase molecular evolution of the nucleoside monophosphate kinase family,

6.

(1998) Identification of a novel adenylate kinase system in brain:cloning of the fourth adenylate kinase,

7.

(1996) Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding,

8.

(1988) Structure of the complex of adenylate kinase from Escherichia coli with the inhibitor P1, P5-di(adenosine-5'-)pentaphosphate,

9.

(1995) High-resolution structures of adenylate kinase from yeast ligated with inhibitor Ap5A,showing the pathway of phosphoryl transfer,

10.

(1997) catalysis and supramolecular assembly of adenylate kinase from maize,

11.

(1999) Nucleoside monophosphate kinases:structure,mechanism,and substrate specificity,

12.

(1999) Distribution and developmental changes of adenylate kinase isozymes in the rat brain:loclization of adenylate kinase 1 in the olfactory bulb,

13.

(2000) Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement,

14.

(2000) Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress,

15.

(2004) Structure and dynamic studies on ligand-free adenylate kinase from Mycobacterium tuberculosis revealed a closed conformation that can be related to the reduced catalytic activity,

16.

(1999) A new subfamily of short bacterial adenylate kinases with the Mycobacterium tuberculosis enzyme as a model:a predictive and experimental study,

17.

(2005) 단백질 공학에 의해 활성이 강화된 mycobacterial adenylate kinase 변이체의 작성,

18.

(2004) Adenylate kinase I does not affect cellular growth characteristics under normal and metabolic stress conditions,

19.

(2001) Adenylate kinase as a virulence factor of Pseudomonas aeruginosa,

Tuberculosis & Respiratory Diseases